協和キリンの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2014/12/02 | 1,285 | 1,300 | 1,285 | 1,298 | -1 | -0.1% | 722,000 |
| 2014/12/01 | 1,284 | 1,306 | 1,284 | 1,299 | +10 | +0.8% | 794,000 |
| 2014/11/28 | 1,278 | 1,293 | 1,278 | 1,289 | +12 | +0.9% | 825,000 |
| 2014/11/27 | 1,293 | 1,297 | 1,277 | 1,277 | -22 | -1.7% | 655,000 |
| 2014/11/26 | 1,295 | 1,305 | 1,288 | 1,299 | +15 | +1.2% | 1,064,000 |
| 2014/11/25 | 1,325 | 1,328 | 1,284 | 1,284 | -18 | -1.4% | 1,802,000 |
| 2014/11/21 | 1,282 | 1,305 | 1,272 | 1,302 | +24 | +1.9% | 1,521,000 |
| 2014/11/20 | 1,291 | 1,293 | 1,276 | 1,278 | ±0 | ±0% | 789,000 |
| 2014/11/19 | 1,270 | 1,287 | 1,270 | 1,278 | +5 | +0.4% | 1,110,000 |
| 2014/11/18 | 1,275 | 1,282 | 1,264 | 1,273 | +8 | +0.6% | 1,028,000 |
| 2014/11/17 | 1,299 | 1,303 | 1,256 | 1,265 | -47 | -3.6% | 1,235,000 |
| 2014/11/14 | 1,326 | 1,326 | 1,290 | 1,312 | -4 | -0.3% | 2,089,000 |
| 2014/11/13 | 1,300 | 1,319 | 1,297 | 1,316 | +8 | +0.6% | 969,000 |
| 2014/11/12 | 1,300 | 1,322 | 1,299 | 1,308 | +20 | +1.6% | 1,290,000 |
| 2014/11/11 | 1,272 | 1,291 | 1,270 | 1,288 | +14 | +1.1% | 946,000 |
| 2014/11/10 | 1,274 | 1,275 | 1,264 | 1,274 | -6 | -0.5% | 801,000 |
| 2014/11/07 | 1,276 | 1,284 | 1,268 | 1,280 | +6 | +0.5% | 1,037,000 |
| 2014/11/06 | 1,310 | 1,310 | 1,260 | 1,274 | -32 | -2.5% | 1,914,000 |
| 2014/11/05 | 1,284 | 1,310 | 1,284 | 1,306 | +19 | +1.5% | 1,405,000 |
| 2014/11/04 | 1,326 | 1,326 | 1,286 | 1,287 | +15 | +1.2% | 2,065,000 |
| 2014/10/31 | 1,227 | 1,281 | 1,227 | 1,272 | +54 | +4.4% | 2,267,000 |
| 2014/10/30 | 1,223 | 1,231 | 1,217 | 1,218 | -1 | -0.1% | 1,118,000 |
| 2014/10/29 | 1,211 | 1,225 | 1,201 | 1,219 | +21 | +1.8% | 1,544,000 |
| 2014/10/28 | 1,201 | 1,218 | 1,180 | 1,198 | -13 | -1.1% | 759,000 |
| 2014/10/27 | 1,215 | 1,219 | 1,208 | 1,211 | +4 | +0.3% | 785,000 |
| 2014/10/24 | 1,213 | 1,217 | 1,200 | 1,207 | +14 | +1.2% | 1,143,000 |
| 2014/10/23 | 1,200 | 1,207 | 1,186 | 1,193 | -20 | -1.6% | 973,000 |
| 2014/10/22 | 1,190 | 1,213 | 1,190 | 1,213 | +36 | +3.1% | 1,051,000 |
| 2014/10/21 | 1,201 | 1,207 | 1,176 | 1,177 | -32 | -2.6% | 1,172,000 |
| 2014/10/20 | 1,188 | 1,209 | 1,179 | 1,209 | +41 | +3.5% | 1,759,000 |
| 2014/10/17 | 1,217 | 1,220 | 1,168 | 1,168 | -53 | -4.3% | 1,676,000 |
| 2014/10/16 | 1,223 | 1,239 | 1,219 | 1,221 | -25 | -2% | 1,308,000 |
| 2014/10/15 | 1,258 | 1,260 | 1,238 | 1,246 | -6 | -0.5% | 1,241,000 |
| 2014/10/14 | 1,248 | 1,268 | 1,248 | 1,252 | -26 | -2% | 1,540,000 |
| 2014/10/10 | 1,287 | 1,292 | 1,273 | 1,278 | -26 | -2% | 1,538,000 |
| 2014/10/09 | 1,323 | 1,325 | 1,303 | 1,304 | -8 | -0.6% | 727,000 |
| 2014/10/08 | 1,305 | 1,323 | 1,302 | 1,312 | -7 | -0.5% | 769,000 |
| 2014/10/07 | 1,316 | 1,329 | 1,316 | 1,319 | -13 | -1% | 757,000 |
| 2014/10/06 | 1,327 | 1,343 | 1,320 | 1,332 | +21 | +1.6% | 947,000 |
| 2014/10/03 | 1,300 | 1,311 | 1,290 | 1,311 | -1 | -0.1% | 900,000 |
| 2014/10/02 | 1,339 | 1,354 | 1,311 | 1,312 | -30 | -2.2% | 1,200,000 |
| 2014/10/01 | 1,344 | 1,349 | 1,333 | 1,342 | -3 | -0.2% | 740,000 |
| 2014/09/30 | 1,342 | 1,346 | 1,332 | 1,345 | +4 | +0.3% | 1,116,000 |
| 2014/09/29 | 1,341 | 1,347 | 1,335 | 1,341 | +3 | +0.2% | 602,000 |
| 2014/09/26 | 1,316 | 1,342 | 1,315 | 1,338 | -1 | -0.1% | 873,000 |
| 2014/09/25 | 1,352 | 1,352 | 1,325 | 1,339 | -3 | -0.2% | 912,000 |
| 2014/09/24 | 1,335 | 1,347 | 1,331 | 1,342 | +2 | +0.1% | 651,000 |
| 2014/09/22 | 1,332 | 1,344 | 1,326 | 1,340 | -3 | -0.2% | 1,111,000 |
| 2014/09/19 | 1,353 | 1,354 | 1,336 | 1,343 | +2 | +0.1% | 1,173,000 |
| 2014/09/18 | 1,344 | 1,350 | 1,339 | 1,341 | +7 | +0.5% | 1,042,000 |
2551～
2600
件表示中 / 3698件
類似銘柄と比較する
現在ご覧いただいている「協和キリン」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 協和キリン | 217,400円 | -3.5% | -11.3% | 2.76% | 19.97倍 | 1.34倍 |
|
キリン傘下。医薬品、バイオが主力。独自の抗体高活性化技術に強み。富士フイルムと提携 |
| アステラス薬 | 135,300円 | +0.9% | +380.2% | 5.76% | 18.63倍 | 1.60倍 |
|
医薬品国内２位。開発技術起点の研究開発体制。前立腺がん薬が柱。遺伝子・細胞治療技術育成 |
| 塩野義 | 220,700円 | +20.9% | +10.6% | 2.99% | 10.43倍 | 1.38倍 |
|
抗ＨＩＶ薬が大型製品に。感染症、疼痛・中枢神経領域に強み。米国に積極展開。欧州、アジア開拓 |
| エーザイ | 388,100円 | +1.7% | -2.9% | 4.12% | 25.46倍 | 1.34倍 |
|
神経系、がん領域に強み。認知症薬は米バイオジェンと、抗がん薬では米メルクと国際協業推進 |
| 小野薬 | 150,100円 | +0.6% | +43.3% | 5.33% | 10.52倍 | 0.90倍 |
|
医療用医薬品専業の中堅。自社開発品多い。先駆的がん免疫阻害剤「オプジーボ」が成長牽引 |
市場注目の銘柄
チャート関連のコラム
